EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis

Mingliang Chen, Zhihao Shi, Yuqiu Sun, Haoran Ning, Xinyu Gu, Lei Zhang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021607 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mingliang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D and Promotion Projects in Henan Province, Key Scientific Research Projects of Colleges and Universities in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, characterized by excessive iron accumulation and lipid peroxidation, is a novel form of iron-dependent cell death, which is morphologically, genetically, and biochemically distinct from other known cell death types, such as apoptosis, necrosis, and autophagy. Emerging evidence shows that glutathione peroxidase 4 (GPX4), a critical core regulator of ferroptosis, plays an essential role in protecting cells from ferroptosis by removing the product of iron-dependent lipid peroxidation. The fast-growing studies on ferroptosis in cancer have boosted a perspective on its use in cancer therapeutics. In addition, significant progress has been made in researching and developing tumor therapeutic drugs targeting GPX4 based on ferroptosis, especially in acquired drug resistance. Selenium modulates GPX4-mediated ferroptosis, and its existing form, selenocysteine (Sec), is the active center of GPX4. This review explored the structure and function of GPX4, with the overarching goal of revealing its mechanism and potential application in tumor therapy through regulating ferroptosis. A deeper understanding of the mechanism and application of GPX4-mediated ferroptosis in cancer therapy will provide new strategies for the research and development of antitumor drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsHumansPhospholipid Hydroperoxide Glutathione PeroxidaseCell DeathIronLipid PeroxidationGlutathione PeroxidaseGlutathione

Stichwörter der Autor:innen

anti-tumorcancerferroptosisglutathione peroxidase 4selenocysteine

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseIronGlutathione PeroxidaseGlutathione

Autor:innen und Institutionen

  • School of Basic Medical Science, Henan University, Kaifeng 475004, China.
  • School of Clinical Medicine, Henan University, Kaifeng 475004, China.

ORCID-Profile: Lei Zhang

Förderung

  • National Natural Science Foundation of China
  • Key R&D and Promotion Projects in Henan Province
  • Key Scientific Research Projects of Colleges and Universities in Henan Province

Zitieren

APA

Chen, M., Shi, Z., Sun, Y., Ning, H., Gu, X., & Zhang, L. (2023). Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021607

Vancouver

Chen M, Shi Z, Sun Y, Ning H, Gu X, Zhang L. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021607

BibTeX
@article{Chen2023,
  author = {Chen, Mingliang and Shi, Zhihao and Sun, Yuqiu and Ning, Haoran and Gu, Xinyu and Zhang, Lei},
  title = {Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021607}
}
Kostenlos starten →